PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

T Dorff; M Rettig; JP Machiels; M Lolkema; K Autio; Richard Greil; S Rottey; N Adra; M Salvati; S Poon; D Tan; G Jurida; H Kouros-Mehr; K Fizazi; B Tran; L Horvath

doi:10.1136/jitc-2020-SITC2020.0340

PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

T Dorff, M Rettig, JP Machiels, M Lolkema, K Autio, Richard Greil, S Rottey, N Adra, M Salvati, S Poon, D Tan, G Jurida, H Kouros-Mehr, K Fizazi, B Tran, L Horvath

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to conference › Abstract

Original language	English
DOIs	https://doi.org/10.1136/jitc-2020-SITC2020.0340
Publication status	Published - 2020

Access to Document

10.1136/jitc-2020-SITC2020.0340

Cite this

Dorff, T., Rettig, M., Machiels, JP., Lolkema, M., Autio, K., Greil, R., Rottey, S., Adra, N., Salvati, M., Poon, S., Tan, D., Jurida, G., Kouros-Mehr, H., Fizazi, K., Tran, B., & Horvath, L. (2020). PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. https://doi.org/10.1136/jitc-2020-SITC2020.0340

@conference{89c861b696a741d2aaa9bc0cc8b8ffbc,

title = "PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER",

author = "T Dorff and M Rettig and JP Machiels and M Lolkema and K Autio and Richard Greil and S Rottey and N Adra and M Salvati and S Poon and D Tan and G Jurida and H Kouros-Mehr and K Fizazi and B Tran and L Horvath",

year = "2020",

doi = "10.1136/jitc-2020-SITC2020.0340",

language = "English",

}

Dorff, T, Rettig, M, Machiels, JP, Lolkema, M, Autio, K, Greil, R, Rottey, S, Adra, N, Salvati, M, Poon, S, Tan, D, Jurida, G, Kouros-Mehr, H, Fizazi, K, Tran, B & Horvath, L 2020, 'PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER'. https://doi.org/10.1136/jitc-2020-SITC2020.0340

TY - CONF

T1 - PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

AU - Dorff, T

AU - Rettig, M

AU - Machiels, JP

AU - Lolkema, M

AU - Autio, K

AU - Greil, Richard

AU - Rottey, S

AU - Adra, N

AU - Salvati, M

AU - Poon, S

AU - Tan, D

AU - Jurida, G

AU - Kouros-Mehr, H

AU - Fizazi, K

AU - Tran, B

AU - Horvath, L

PY - 2020

Y1 - 2020

U2 - 10.1136/jitc-2020-SITC2020.0340

DO - 10.1136/jitc-2020-SITC2020.0340

M3 - Abstract

ER -